Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Extracorporeal Shock Wave Therapy on Spasticity, Mobility, Motor Function, and Health-Related Quality of Life in Stroke Survivors: A Prospective Randomized Sham-Controlled Trial

NCT07523243 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.

NCT NCT07523243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07523243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Extracorporeal Shock Wave Therapy on Spasticity, Mobility, Motor Function, and Health-Related Quality of Life in Stroke Survivors: A Prospective Randomized Sham-Controlled Trial
Lead sponsor
Istanbul Medipol University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
June 20, 2026
Enrollment
85 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lower limb spasticity, post-stroke spasticity, stroke